OAT2 activators constitute a specialized category of chemical compounds known for their capacity to modulate the activity of the Organic Anion Transporter 2 (OAT2), a key member of the solute carrier family involved in the transport of a diverse range of endogenous and exogenous compounds across cell membranes. OAT2, also referred to as SLC22A7, is expressed in various tissues, particularly in the kidney and liver, where it plays a crucial role in the uptake and clearance of organic anions from the bloodstream. These activators are meticulously designed to interact with OAT2, influencing its transport function by enhancing the uptake or efflux of specific molecules. At the molecular level, the mechanisms through which OAT2 activators exert their effects can be diverse, involving binding to specific sites on the transporter protein, potentially leading to conformational changes that enhance its substrate affinity and transport kinetics.
The study of OAT2 activators is instrumental in advancing our understanding of renal and hepatic clearance processes, and the broader field of pharmacokinetics. Researchers in this field primarily focus on elucidating the precise molecular mechanisms by which these compounds impact OAT2's function and their downstream effects on the transport of various organic anions. Understanding the role of OAT2 activators contributes to our broader knowledge of the interplay between transporters and xenobiotics.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Known inducer of various drug transporters through the activation of nuclear receptors like PXR. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
PPARγ agonist that might influence the expression of various drug transporters. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Another PPARγ agonist potentially affecting drug transporter expression. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Might influence OAT2 expression in certain cellular contexts. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid that can modulate various gene expressions; potential influence on OAT2. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
Regulates various genes through the vitamin D receptor; could influence OAT2 expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Affects various signaling pathways; potential to modulate OAT2 expression in metabolic contexts. | ||||||
L-3,3′,5-Triiodothyronine, Sodium Salt | 55-06-1 | sc-205725 | 250 mg | $115.00 | ||
Might influence OAT2 expression in the context of metabolic regulation. | ||||||
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
Elevated glucose might affect OAT2 expression in certain pathological states like diabetes. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Can influence various transporters; potential effects on OAT2 expression in specific contexts. | ||||||